Work

Abstract 2938: A novel OX40 agonist licenses systemic anti-tumor immunity to overcome local immune suppression induced by well-established tumors

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am10-2938

Authors: Angela D. Pardee, Alan L. Epstein, Walter J. Storkus

Institutions: University of Pittsburgh, University of Southern California

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2034586607

Cites:

Cited by:

Related to: 10